Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim™ System in the Treatment of Patients Diagnosed With Overactive Bladder (OASIS - OverActive Bladder StImulation System Study)

NCT03596671 is registered in ClinicalTrials.gov with BlueWind Medical as lead sponsor.

NCT NCT03596671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03596671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim™ System in the Treatment of Patients Diagnosed With Overactive Bladder (OASIS - OverActive Bladder StImulation System Study)
Lead sponsor
BlueWind Medical
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2019
Completion date
January 24, 2025
Enrollment
282 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

treatment of patients suffering from overactive bladder (oab)